E-LIB Suche - Ergebnisse für: Sharp, Cierra

1

Neutral ceramidase deficiency protects against cisplatin-in..:

Sears, Sophia M. ; Dupre, Tess V. ; Shah, Parag P....
Journal of Lipid Research. 63 (2022) 3 - p. 100179 , 2022

2

Neutral ceramidase deficiency protects against cisplatin-in..:

Sophia M. Sears ; Tess V. Dupre ; Parag P. Shah...
http://www.sciencedirect.com/science/article/pii/S0022227522000128. , 2022

Link: https://doi.org/10.1016/..

3

Neutral ceramidase deficiency protects against cisplatin-in..:

Sears, Sophia M ; Dupre, Tess V ; Shah, Parag P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953688/. , 2022

Link: http://www.ncbi.nlm.nih...

4

Newborn Drug Screening: Differential Outcome Using Meconium..:

Algahmdi, Norah ; Sharp, Cierra ; Robinson, Tonya.
American Journal of Clinical Pathology. 154 (2020) Supplement_1 - p. S2-S3 , 2020

Link: https://doi.org/10.1093/..

5

A Shared Diagnostic Stewardship Approach toward Improving A..:

Sharp, Cierra N ; Fletcher, Anita ; Muluhngwi, Penn...
The Journal of Applied Laboratory Medicine. 6 (2020) 2 - p. 387-396 , 2020

Link: https://doi.org/10.1093/..

6

A Shared Diagnostic Stewardship Approach to Autoimmune Ence..:

Sharp, Cierra ; Muluhngwi, Penn ; Fletcher, Anita...
American Journal of Clinical Pathology. 154 (2020) Supplement_1 - p. S2-S2 , 2020

Link: https://doi.org/10.1093/..

7

ELISA-based detection of Open Reading Frame protein 1 in pa..:

Sharp, Cierra N. ; Korte, Erik A. ; Hosseinejad, Keivan...
Clinica Chimica Acta. 507 (2020) - p. 1-6 , 2020

Link: https://doi.org/10.1016/..

8

Integration of an Evidence-Based Algorithm for Inpatient Au..:

Fletcher, Anita ; Sharp, Cierra ; Sweeney, Michael
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

9

C57BL/6 mice require a higher dose of cisplatin to induce r..:

Sears, Sophia M ; Sharp, Cierra N ; Krueger, Austin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642885/. , 2020

Link: http://www.ncbi.nlm.nih...

10

Verification of Newly FDA-Approved Kappa and Lambda Free Li..:

Muluhngwi, Penn ; Sharp, Cierra N. ; Pozzi, Nicole..
The Journal of Applied Laboratory Medicine. 4 (2019) 3 - p. 323-330 , 2019

Link: https://doi.org/10.1373/..

11

Long interspersed nuclear element-1 mobilization as a targe..:

Lavasanifar, Afsaneh ; Sharp, Cierra N. ; Korte, Erik A....
Clinica Chimica Acta. 493 (2019) - p. 52-62 , 2019

Link: https://doi.org/10.1016/..

12

Moderate aging does not exacerbate cisplatin-induced kidney..:

Sharp, Cierra N ; Doll, Mark ; Dupre, Tess V..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383196/. , 2019

Link: http://www.ncbi.nlm.nih...

13

Polypharmacy: A Healthcare Conundrum with a Pharmacogenetic..:

Sharp, Cierra N ; Linder, Mark W ; Valdes, Roland
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195220/. , 2019

Link: http://www.ncbi.nlm.nih...

14

Cisplatin Effects in Lung Adenocarcinoma-bearing Mice, Alon..:

Sharp, Cierra N.
Toxicologic Pathology. 46 (2018) 8 - p. 1049-1050 , 2018

Link: https://doi.org/10.1177/..

15

Subclinical kidney injury induced by repeated cisplatin adm..:

Sharp, Cierra N ; Doll, Mark A ; Megyesi, Judit...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087791/. , 2018

Link: http://www.ncbi.nlm.nih...